339 related articles for article (PubMed ID: 35999629)
1. Multimodal targeting of glioma with functionalized nanoparticles.
Marei HE
Cancer Cell Int; 2022 Aug; 22(1):265. PubMed ID: 35999629
[TBL] [Abstract][Full Text] [Related]
2. Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma.
Qiao L; Yang H; Shao XX; Yin Q; Fu XJ; Wei Q
Mol Pharm; 2022 Jul; 19(7):1927-1951. PubMed ID: 35499303
[TBL] [Abstract][Full Text] [Related]
3. Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.
Wu Y; Qian Y; Peng W; Qi X
PeerJ; 2023; 11():e15571. PubMed ID: 37426416
[TBL] [Abstract][Full Text] [Related]
4. The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches.
Agrahari V
Neural Regen Res; 2017 Feb; 12(2):197-200. PubMed ID: 28400793
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy Based on Lipid Nanoparticles as Non-viral Vectors for Glioma Treatment.
Luiz MT; Tofani LB; Araújo VHS; Di Filippo LD; Duarte JL; Marchetti JM; Chorilli M
Curr Gene Ther; 2021; 21(5):452-463. PubMed ID: 33390137
[TBL] [Abstract][Full Text] [Related]
6. Activation of cancer immunotherapy by nanomedicine.
Wang L; Xu H; Weng L; Sun J; Jin Y; Xiao C
Front Pharmacol; 2022; 13():1041073. PubMed ID: 36618938
[TBL] [Abstract][Full Text] [Related]
7. Challenges and advances for glioma therapy based on inorganic nanoparticles.
Hu D; Xia M; Wu L; Liu H; Chen Z; Xu H; He C; Wen J; Xu X
Mater Today Bio; 2023 Jun; 20():100673. PubMed ID: 37441136
[TBL] [Abstract][Full Text] [Related]
8. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
9. Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma.
Wang H; Chao Y; Zhao H; Zhou X; Zhang F; Zhang Z; Li Z; Pan J; Wang J; Chen Q; Liu Z
ACS Nano; 2022 Jan; 16(1):664-674. PubMed ID: 34978418
[TBL] [Abstract][Full Text] [Related]
10. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment.
Luiz MT; Delello Di Filippo L; Tofani LB; de Araújo JTC; Dutra JAP; Marchetti JM; Chorilli M
Int J Pharm; 2021 Jul; 604():120758. PubMed ID: 34090991
[TBL] [Abstract][Full Text] [Related]
11. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
12. Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.
Wanjale MV; Kumar GSV
Expert Opin Drug Deliv; 2017 Jun; 14(6):811-824. PubMed ID: 27690671
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
14. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
[TBL] [Abstract][Full Text] [Related]
15. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.
Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W
Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy.
Wang B; Tang M; Yuan Z; Li Z; Hu B; Bai X; Chu J; Xu X; Zhang XQ
Bioact Mater; 2022 Oct; 16():232-248. PubMed ID: 35386310
[TBL] [Abstract][Full Text] [Related]
17. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
[TBL] [Abstract][Full Text] [Related]
19. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
20. Current Immunotherapeutic Approaches for Malignant Gliomas.
Han MH; Kim CH
Brain Tumor Res Treat; 2022 Jan; 10(1):1-11. PubMed ID: 35118842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
